AAAAAA
Results: 26-40/40
Authors:
Garnero, P
Sornay-Rendu, E
Delmas, PD
Citation: P. Garnero et al., Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausalwomen, LANCET, 355(9207), 2000, pp. 898-899
Authors:
Garnero, P
Buchs, N
Zekri, J
Rizzoli, R
Coleman, RE
Delmas, PD
Citation: P. Garnero et al., Markers of bone turnover for the management of patients with bone metastases from prostate cancer, BR J CANC, 82(4), 2000, pp. 858-864
Authors:
Garnero, P
Rousseau, JC
Delmas, PD
Citation: P. Garnero et al., Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases, ARTH RHEUM, 43(5), 2000, pp. 953-968
Authors:
Fontana, A
Garnero, P
Delmas, PD
Citation: A. Fontana et al., Markers of bone turnover in diagnosis and monitoring of bone metastases, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 213-226
Authors:
Garnero, P
Darte, C
Delmas, PD
Citation: P. Garnero et al., A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover, BONE, 24(6), 1999, pp. 603-609
Authors:
Delmas, PD
Pornel, B
Felsenberg, D
Garnero, P
Hardy, P
Pilate, C
Dain, MP
Citation: Pd. Delmas et al., A dose-ranging trial of a matrix transdermal 17 beta-estradiol for the prevention of bone loss in early postmenopausal women, BONE, 24(5), 1999, pp. 517-523
Authors:
Garnero, P
Jouvenne, P
Buchs, N
Delmas, PD
Miossec, P
Citation: P. Garnero et al., Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: Assessment with serum type I collagen breakdown products, BONE, 24(4), 1999, pp. 381-385
Authors:
Garnero, P
Citation: P. Garnero, Biochemical markers of bone turnover: Recent data and avenues for the future, REV RHUM, 66(11), 1999, pp. 538-542
Authors:
Meunier, PJ
Vignot, E
Garnero, P
Confavreux, E
Paris, E
Liu-Leage, S
Sarkar, S
Liu, T
Wong, M
Draper, MW
Citation: Pj. Meunier et al., Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene (vol 10, pg 330, 1999), OSTEOPOR IN, 10(5), 1999, pp. 433-433
Authors:
Meunier, PJ
Vignot, E
Garnero, P
Confavreux, E
Paris, E
Liu-Leage, S
Sarkar, S
Liu, T
Wong, M
Draper, MW
Citation: Pj. Meunier et al., Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene, OSTEOPOR IN, 10(4), 1999, pp. 330-336
Authors:
Garnero, P
Sornay-Rendu, E
Duboeuf, F
Delmas, PD
Citation: P. Garnero et al., Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: The OFELY study, J BONE MIN, 14(9), 1999, pp. 1614-1621
Authors:
Bauer, DC
Sklarin, PM
Stone, KL
Black, DM
Nevitt, MC
Ensrud, KE
Arnaud, CD
Genant, HK
Garnero, P
Delmas, PD
Lawaetz, H
Cummings, SR
Citation: Dc. Bauer et al., Biochemical markers of bone turnover and prediction of hip bone loss in older women: The study of osteoporotic fractures, J BONE MIN, 14(8), 1999, pp. 1404-1410
Authors:
Garnero, P
Delmas, PD
Citation: P. Garnero et Pd. Delmas, Variability and response of urinary resorption markers to hormone replacement therapy, J BONE MIN, 14(3), 1999, pp. 470-471
Authors:
Garnero, P
Tsouderos, Y
Marton, I
Pelissier, C
Varin, C
Delmas, PD
Citation: P. Garnero et al., Effects of intranasal 17 beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women, J CLIN END, 84(7), 1999, pp. 2390-2397
Authors:
Garnero, P
Dargent-Molina, P
Hans, D
Schott, AM
Breart, G
Meunier, PJ
Delmas, PD
Citation: P. Garnero et al., Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study, OSTEOPOR IN, 8(6), 1998, pp. 563-569